Theoretical investigation on the glycan-binding specificity of Agrocybe cylindracea galectin using molecular modeling and molecular dynamics simulation studies

Journal of Molecular Recognition : JMR
Ponnusamy ParasuramanKasinadar Veluraja

Abstract

Galectins are β-galactoside binding proteins which have the ability to serve as potent antitumor, cancer biomarker, and induce tumor cell apoptosis. Agrocybe cylindracea galectin (ACG) is a fungal galectin which specifically recognizes α(2,3)-linked sialyllactose at the cell surface that plays extensive roles in the biological recognition processes. To investigate the change in glycan-binding specificity upon mutations, single point and double point site-directed in silico mutations are performed at the binding pocket of ACG. Molecular dynamics (MD) simulation studies are carried out for the wild-type (ACG) and single point (ACG1) and double point (ACG2) mutated ACGs to investigate the dynamics of substituted mutants and their interactions with the receptor sialyllactose. Plausible binding modes are proposed for galectin-sialylglycan complexes based on the analysis of hydrogen bonding interactions, total pair-wise interaction energy between the interacting binding site residues and sialyllactose and binding free energy of the complexes using molecular mechanics-Poisson-Boltzmann surface area. Our result shows that high contribution to the binding in different modes is due to the direct and water-mediated hydrogen bonds. The bin...Continue Reading

References

Oct 1, 1993·Glycobiology·M KimE Gorelik
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Jan 1, 1996·Annual Review of Biochemistry·W I Weis, K Drickamer
Feb 1, 1997·Glycoconjugate Journal·F YagiI J Goldstein
Mar 21, 1998·Biochemistry and Molecular Biology International·N A Devi, A G Rao
Dec 10, 1998·Nucleic Acids Research·M M GromihaA Sarai
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Dec 23, 1999·Current Opinion in Structural Biology·M Vijayan, N Chandra
Oct 26, 2000·Nature·M O Hengartner
Feb 19, 2002·Chemical Reviews·Halina Lis, Nathan Sharon
Jun 19, 2002·Accounts of Chemical Research·Martin Karplus
Aug 29, 2002·Nature Structural Biology·Martin Karplus, J Andrew McCammon
Dec 25, 2003·Journal of Biomolecular Structure & Dynamics·D Jeya Sundara Sharmila, K Veluraja
Feb 26, 2004·Bioorganic & Medicinal Chemistry·Mohammad Mehedi MasudHiroaki Sawai
Apr 6, 2004·Structure·Piers J WalserNenad Ban
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Jul 2, 2004·Glycobiology·Nathan Sharon, Halina Lis
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Mar 24, 2005·British Journal of Cancer·G A Rabinovich
May 28, 2005·Journal of Biomolecular Structure & Dynamics·Kasinadar Veluraja, Claudio J Margulis
Jul 30, 2005·Journal of Molecular Biology·Mizuho BanFumio Yagi
Oct 4, 2005·Journal of Computational Chemistry·David A CaseRobert J Woods
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Jun 20, 2006·Glycobiology·Nagasuma R ChandraM N Prathima
Jul 18, 2006·Nucleic Acids Research·Vijaya ParthibanDietmar Schomburg
Nov 27, 2007·Glycoconjugate Journal·Deepa DamodaranAvadhesha Surolia
Dec 5, 2008·Journal of the American Chemical Society·Renuka KadirvelrajRobert J Woods
Feb 18, 2010·Journal of the American Chemical Society·Steven E WheelerK N Houk
Sep 3, 2010·The Journal of Biological Chemistry·Emma SalomonssonHakon Leffler
May 5, 2011·Biophysical Journal·Ignacia Echeverria, L Mario Amzel
Apr 11, 2012·Journal of Computer-aided Molecular Design·Jeyasigamani F A SelvinKasinadar Veluraja
Jan 29, 2013·Chemical Society Reviews·Julie ArnaudAnne Imberty
Apr 20, 2010·Cancers·Vitaly BalanAvraham Raz
Jul 22, 2014·Angewandte Chemie·Julie ArnaudAnne Imberty

❮ Previous
Next ❯

Citations

Apr 10, 2018·Journal of Molecular Recognition : JMR·Ramakrishna DumpatiUma Vuruputuri
May 11, 2021·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·Abdulahad DoganOmer Faruk Keles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis